Session 33-34 Clinical Session 7-8

 

Monday, September 4
10:20 – 12:30 am

Room 15

 

 

Controversy on classification/treatments of upper and lower esophageal cancers – Debate

 

Chairs: Olivier Huber (Switzerland) – William Allum (UK)

Panel: Giovanni de Manzoni (Italy) – Dietmar Lorenz (Germany)

 

 

Sessions 33 – Cervical cancers

• Surgical aspects of proximal esophageal cancer. Katja Ott (Germany)
• Exclusive radio-chemotherapy. Thomas Zilli (Switzerland)

 

Debate

 

 

Sessions 34 – Cancers at the EG junction

Chairs: Hans-Joachim Meyer (Germany) – Giovanni de Manzoni (Italy)

Discussants:  Bruno Zilberstein (Brazil) – William Allum (UK)

• Rising incidence of adenocarcinoma of the EG junction: what is new in 2017?
  Elfriede Bollschweiler (Germany)

• Preoperative staging and classifi cation. William Allum (UK)
• Lymph node involvement according to esophageal invasion. Giovanni de Manzoni (Italy)
• Siewert II – esophagectomy or gastrectomy. Yves Borbely (Switzerland)
• Future clinical trial comparing esophagectomy with gastrectomy. Thomas Schmidt (Germany)
• Ivor-Lewis vs McKeown procedures for EGJ cancers. S.M. Chandramohan (India)
• Minimal invasive vs open procedure. Lee L. Swanström (USA-France)
• Extent of lymphadenectomy. Klaus Emmanuel (Austria)
• Which neoadjuvant treatment?

– Pro chemotherapy. Salah AL-Batran (Germany)

– Pro radio-chemotherapy. Fredrik Klevebro (Sweden)

• Oligo-metastatic cancer – Impact of surgery. Stefan P. Mönig (Switzerland)